GPT Healthcare Limited IPO for subscription on February 22, 2024 and closes on February 26, 2024.
GPT Healthcare IPO Details: The IPO have issue is a combination of fresh issue of 0.22 crore shares aggregating to Rs 40.00 crores and offer for sale of 2.61 crore shares aggregating to Rs 485.14 crores. GPT Healthcare IPO will list on BSE, NSE with tentative listing date fixed on Thursday, February 29, 2024.
GPT Healthcare IPO Details
IPO Date | February 22, 2024 to February 26, 2024 |
Face Value | Rs 10 per share |
Price Band | Rs 177 to 186 per share |
Lot Size | 80 Shares |
Total Issue Size | 28,233,323 shares (Total up to 525.14 Cr) |
Fresh Issue | 2,150,537 shares (Total up to 40 Cr) |
Offer for Sale | 26,082,786 shares of Rs10 (Total up to 485.14 Cr) |
Issue Type | Book Built Issue IPO |
Listing At | BSE, NSE |
Share holding pre issue | 79,904,286 |
Share holding post issue | 82,054,823 |
GPT Healthcare IPO Price: The IPO has fixed price is set at Rs 177 to Rs 186 per share.
GPT Healthcare IPO Subscription Status: The IPO have open for subscription on February 22, 2024 and closes on February 26, 2024.
GPT Healthcare IPO Lot Size: The IPO minimum lot size for an application is 80 Shares and minimum amount of investment required by retail investors is Rs 14,880.
GPT Healthcare IPO GMP: GPT Healthcare IPO GMP today is Rs 16, with the price band of 186.00, and estimated listing price is Rs 202.
GPT Healthcare IPO Allotment: The IPO allotment is expected to be finalized on Tuesday, February 27, 2024.
GPT Healthcare IPO Promoter Holding: GPT Sons Private Limited, Dwarika Prasad Tantia, Dr. Om Tantia, and Shree Gopal Tantia are the promoters of the company.
- Share Holding Pre Issue: 67.34%
GPT Healthcare IPO Timeline
IPO Open Date | Thursday, February 22, 2024 |
IPO Close Date | Monday, February 26, 2024 |
Basis of Allotment | Tuesday, February 27, 2024 |
Initiation of Refunds | Wednesday, February 28, 2024 |
Credit of Shares to Demat | Wednesday, February 28, 2024 |
Listing Date | Thursday, February 29, 2024 |
GPT Healthcare IPO Review: GPT Healthcare IPO Review By Dilip Davda on February 20, 2024.
- GHL is eastern region centric healthcare service provider.
- It operates with 561 beds and has the lowest capacity against its listed peers.
- The company marked growth in its top lines, but suffered a setback for FY23 in its bottom line.
- Based on its FY24 super earnings, the issue appears fully priced.
- Well-informed investors may park moderate funds for the medium to long term rewards.
GPT Healthcare IPO Buy or Not:
- Brokers 2: 0 Subscribe
- Members: 1 Subscribe
• Disclaimer: The above article is meant for informational purposes only, any investment stock market & mutual fund please advice financial expert.
** Stay tuned to KhobarTime.com for more Financial news like this !